- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06797700
Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis (RFPMDLS)
March 4, 2025 updated by: Xinyun li, The First People's Hospital of Yunnan
Prediction of Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis Based on Spine MRI
This is a retrospectively observational study.
The goal of this observational study is to analyze the risk factors of paraspinal muscles associated with the occurrence of spondylolisthesis in patients with degenerative lumbar spondylolisthesis(DLS) and to construct a predictive model.
The main question it aims to answer is: Which paraspinal muscle changes are risk factors for DLS?
We will collect the information of patients who have undergone lumbar MRI in our hospital and have been diagnosed with back pain ( including spondylolisthesis or no spondylolisthesis) during the period from 2022 to 2024.The collected data included gender, age, body mass index (BMI), diabetes, hypertension, occupation and imaging parameters.
We will then retrospectively analyze the risk factors associated with lumbar spondylolisthesis.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xinyun Li
- Phone Number: 86+15750359757
- Email: 15750359757@163.com
Study Locations
-
-
Yunnan
-
Kunming, Yunnan, China, 650032
- The First People's Hospital of Yunnan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who have undergone lumbar MRI in our hospital and have been diagnosed with back pain ( including spondylolisthesis or no spondylolisthesis) during the period from 2022 to 2024.
Description
Inclusion Criteria:
- Patients who presented to our hospital with back pain(the diagnosis was spondylolisthesis or no spondylolisthesis);
- Patients older than 50 years;
- Patients with complete clinical data and magnetic resonance imaging (MRI) before surgery.
Exclusion Criteria:
- The patient has previous spinal surgery;
- Patients with lumbar tumor,lumbar infection and lumbar tuberculosis;
- Patients with incomplete MRI sequence.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group A
patients without lumbar spondylolisthesis
|
|
Group B
patients with lumbar spondylolisthesis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the MF FCSA
Time Frame: Two weeks before treatment
|
The functional cross-sectional areas of the multifidus muscl.Measurement it on axial T2-weighted magnetic resonance (MR) images from the L4 vertebral body levels
|
Two weeks before treatment
|
|
the ES FCSA
Time Frame: Two weeks before treatment
|
The functional cross-sectional areas of the erector spinae.Measurement it on axial T2-weighted magnetic resonance (MR) images from the L4 vertebral body levels
|
Two weeks before treatment
|
|
the MF CSA
Time Frame: Two weeks before treatment
|
the total cross-sectional areas of the multifidus muscl.Measurement it on axial T2-weighted magnetic resonance (MR) images from the L4 vertebral body levels
|
Two weeks before treatment
|
|
the ES CSA
Time Frame: Two weeks before treatment
|
the total cross-sectional areas of the erector spinae.Measurement it on axial T2-weighted magnetic resonance (MR) images from the L4 vertebral body levels
|
Two weeks before treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SMI
Time Frame: Two weeks before treatment
|
The skeletal muscle index.SMI = l CSA of muscle on an axial scan (expressed as cm2) divided by the square of the patient's height (expressed as cm2).
|
Two weeks before treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 6, 2025
Primary Completion (Estimated)
April 30, 2025
Study Completion (Estimated)
August 31, 2025
Study Registration Dates
First Submitted
January 23, 2025
First Submitted That Met QC Criteria
January 23, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 4, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KHLL2025-KY047
- 2024JSKFKT-17 (Other Grant/Funding Number: Yunnan Spinal Cord Disease Clinical Medical Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spine Degeneration
-
University of Missouri-ColumbiaWithdrawnLumbar Spine Degeneration | Cervical Spine DegenerationUnited States
-
Podkarpackie Oncological CenterCompletedSpine Degeneration | Fusion of Spine (Disease)Poland
-
Technical University of MunichNot yet recruiting
-
Second Affiliated Hospital, School of Medicine,...Completed
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
3SpineActive, not recruitingLumbar Spine DegenerationUnited States
-
Virtua Health, Inc.Terminated
-
ElsanCompleted
-
Orthofix Inc.CompletedLumbar Spine DegenerationUnited States
-
3SpineMCRAActive, not recruiting